Header image for  Pareto Securities’ 11th Annual Healthcare Conference
Profile image for Iconovo

Iconovo Exhibitor

Type of industry

Medtech

Presentation
Iconovo was founded in 2013 by people with long experience in inhalation development. The company develops inhalers and associated drug preparations that are used to treat asthma and COPD. However, Iconovo also has the competence to develop products for new types of inhaleddrugs such as vaccines.
By working with Iconovo, pharmaceutical companies and generic companies can access a complete pharmaceutical product, thereby eliminating the complex and costly early stages of the development phase. Iconovo licenses its patented products to customers and offers a faster way to the inhalation market with lower risk and at a lower cost.
More information about the company can be found at www.iconovo.se.
Iconovo is based in Lund and its share (ticker ICO) is listed on Nasdaq First North Growth Market, Stockholm since April 6, 2018. The Company’s Certified Adviser is Erik Penser Bank AB, Box 7405, SE-103 91 Stockholm, phone +46 8 463 80 00, email: certifiedadviser@penser.se.

Presentations

Iconovo

Wednesday September 2, 2020 13:00 - 13:30 CEST Room 1

Contact information

Phone

0462756777

Address

Medicon Village AB

22381 Lund

Sweden

Representatives

Profile image for Johan Wäborg

Johan Wäborg SpeakerExhibitor

CEO
Iconovo

Mea Lindsjö Exhibitor

Executive Assistant
Iconovo